Cargando…

230. Characterization of Antibiotic Timeout Program Strategies Across the United States

BACKGROUND: An antibiotic timeout (ATO) provides a potential opportunity to improve antibiotic utilization and decrease inappropriate antibiotic prescribing. The CDC and Joint Commission suggest ATO as an antimicrobial stewardship program (ASP) action to support optimal antibiotic use. Unfortunately...

Descripción completa

Detalles Bibliográficos
Autores principales: Aljefri, Doaa, Cruce, Caroline, Kinn, Patrick, Kuper, Kristi, Schulz, Lucas T, McCreary, Erin K, Postelnick, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255008/
http://dx.doi.org/10.1093/ofid/ofy210.241
_version_ 1783373857878441984
author Aljefri, Doaa
Cruce, Caroline
Kinn, Patrick
Kuper, Kristi
Schulz, Lucas T
McCreary, Erin K
Postelnick, Michael
author_facet Aljefri, Doaa
Cruce, Caroline
Kinn, Patrick
Kuper, Kristi
Schulz, Lucas T
McCreary, Erin K
Postelnick, Michael
author_sort Aljefri, Doaa
collection PubMed
description BACKGROUND: An antibiotic timeout (ATO) provides a potential opportunity to improve antibiotic utilization and decrease inappropriate antibiotic prescribing. The CDC and Joint Commission suggest ATO as an antimicrobial stewardship program (ASP) action to support optimal antibiotic use. Unfortunately, little is known about the design and implementation of an ATO. Our primary objective was to describe different ATO models established by hospitals across the United States. METHODS: Data describing ATO strategies and ASP efforts were collected via a Qualtrics survey as a part of a multicenter study conducted by Vizient™ member hospitals to research the impact of an ATO on various ASP reporting metrics. RESULTS: Seventy-one hospitals responded to the survey. Twenty (28%) had a formalized ATO. Most institutions utilizing an ATO were community hospitals (60%) and had formalized ASPs (95%). Hospitals with an ATO program trended toward a higher average combined number of ASP physician and pharmacist FTEs than those without a formalized ATO (1.72 vs. 1.2, P = 0.28). Prescribers were responsible for the ATO in 40% of programs (N = 8), 30% were pharmacist-led, and the remainder were multidisciplinary. ATOs were most commonly performed daily (75%) as opposed to on select days of the week and targeted patients receiving antibiotics for 72 hours. Electronic medical record (EMR)-based ATOs (where the EMR prompted the responsible personnel to respond) existed at 14 programs, whereas 4 programs performed an ATO manually through chart review. Forty percent of hospitals conducted ATO on all antibiotics and antifungals; 20% included only antibiotics in their ATO. For the remaining 40% of institutions, only select drugs were included in the ATO. CONCLUSION: Multiple ATO strategies are used in the United States. Most ATOs are electronic-based, performed at 72 hours of antibiotic therapy, inclusive of all antibiotics, and supported by established ASPs. To our knowledge, this is the largest descriptive study on ATO implementation in the United States. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6255008
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62550082018-11-28 230. Characterization of Antibiotic Timeout Program Strategies Across the United States Aljefri, Doaa Cruce, Caroline Kinn, Patrick Kuper, Kristi Schulz, Lucas T McCreary, Erin K Postelnick, Michael Open Forum Infect Dis Abstracts BACKGROUND: An antibiotic timeout (ATO) provides a potential opportunity to improve antibiotic utilization and decrease inappropriate antibiotic prescribing. The CDC and Joint Commission suggest ATO as an antimicrobial stewardship program (ASP) action to support optimal antibiotic use. Unfortunately, little is known about the design and implementation of an ATO. Our primary objective was to describe different ATO models established by hospitals across the United States. METHODS: Data describing ATO strategies and ASP efforts were collected via a Qualtrics survey as a part of a multicenter study conducted by Vizient™ member hospitals to research the impact of an ATO on various ASP reporting metrics. RESULTS: Seventy-one hospitals responded to the survey. Twenty (28%) had a formalized ATO. Most institutions utilizing an ATO were community hospitals (60%) and had formalized ASPs (95%). Hospitals with an ATO program trended toward a higher average combined number of ASP physician and pharmacist FTEs than those without a formalized ATO (1.72 vs. 1.2, P = 0.28). Prescribers were responsible for the ATO in 40% of programs (N = 8), 30% were pharmacist-led, and the remainder were multidisciplinary. ATOs were most commonly performed daily (75%) as opposed to on select days of the week and targeted patients receiving antibiotics for 72 hours. Electronic medical record (EMR)-based ATOs (where the EMR prompted the responsible personnel to respond) existed at 14 programs, whereas 4 programs performed an ATO manually through chart review. Forty percent of hospitals conducted ATO on all antibiotics and antifungals; 20% included only antibiotics in their ATO. For the remaining 40% of institutions, only select drugs were included in the ATO. CONCLUSION: Multiple ATO strategies are used in the United States. Most ATOs are electronic-based, performed at 72 hours of antibiotic therapy, inclusive of all antibiotics, and supported by established ASPs. To our knowledge, this is the largest descriptive study on ATO implementation in the United States. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6255008/ http://dx.doi.org/10.1093/ofid/ofy210.241 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Aljefri, Doaa
Cruce, Caroline
Kinn, Patrick
Kuper, Kristi
Schulz, Lucas T
McCreary, Erin K
Postelnick, Michael
230. Characterization of Antibiotic Timeout Program Strategies Across the United States
title 230. Characterization of Antibiotic Timeout Program Strategies Across the United States
title_full 230. Characterization of Antibiotic Timeout Program Strategies Across the United States
title_fullStr 230. Characterization of Antibiotic Timeout Program Strategies Across the United States
title_full_unstemmed 230. Characterization of Antibiotic Timeout Program Strategies Across the United States
title_short 230. Characterization of Antibiotic Timeout Program Strategies Across the United States
title_sort 230. characterization of antibiotic timeout program strategies across the united states
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255008/
http://dx.doi.org/10.1093/ofid/ofy210.241
work_keys_str_mv AT aljefridoaa 230characterizationofantibiotictimeoutprogramstrategiesacrosstheunitedstates
AT crucecaroline 230characterizationofantibiotictimeoutprogramstrategiesacrosstheunitedstates
AT kinnpatrick 230characterizationofantibiotictimeoutprogramstrategiesacrosstheunitedstates
AT kuperkristi 230characterizationofantibiotictimeoutprogramstrategiesacrosstheunitedstates
AT schulzlucast 230characterizationofantibiotictimeoutprogramstrategiesacrosstheunitedstates
AT mccrearyerink 230characterizationofantibiotictimeoutprogramstrategiesacrosstheunitedstates
AT postelnickmichael 230characterizationofantibiotictimeoutprogramstrategiesacrosstheunitedstates